Harvard Bioscience, Inc. (HBIO) Misses Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $6.50 --0%
Financial Fact:
Total operating expenses: 12.5M
Today's EPS Names:
SYRS, EGRX, AIFC, More
Financial Fact:
Total operating expenses: 12.5M
Today's EPS Names:
SYRS, EGRX, AIFC, More
Join SI Premium – FREE
Harvard Bioscience, Inc. (NASDAQ: HBIO) reported Q4 EPS of $0.02, $0.02 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $28.2 million versus the consensus estimate of $29.2 million.
For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.
For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
- Citi upgrades Bath & Body Works to Buy with $25 price target
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
